M
Marcel Levi
Researcher at University College London Hospitals NHS Foundation Trust
Publications - 630
Citations - 51903
Marcel Levi is an academic researcher from University College London Hospitals NHS Foundation Trust. The author has contributed to research in topics: Disseminated intravascular coagulation & Fibrinolysis. The author has an hindex of 104, co-authored 606 publications receiving 45288 citations. Previous affiliations of Marcel Levi include Academic Medical Center & National Institute for Health Research.
Papers
More filters
Journal ArticleDOI
Disseminated Intravascular Coagulation
Marcel Levi,Ten Cate H +1 more
TL;DR: Bleeding may be the presenting symptom in a patient with disseminated intravascular coagulation, a factor that can complicate decisions about treatment, and the use and subsequent depletion of platelets and coagulating proteins resulting from the ongoing coagulations may induce severe bleeding.
Journal ArticleDOI
Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.
TL;DR: In this paper, the authors presented a study on the effects of haematology drugs on the development of heart disease in patients with hemophilia and showed that they are useful in the treatment of heart failure.
Journal ArticleDOI
ISTH interim guidance on recognition and management of coagulopathy in COVID-19.
Jecko Thachil,Ning Tang,Satoshi Gando,Anna Falanga,Marco Cattaneo,Marcel Levi,Cary Clark,Toshiaki Iba +7 more
TL;DR: This work aims to contribute towards the humanizing of thrombosis and Haemostasis by promoting awareness of the importance of proper diagnosis and treatment of these conditions in patients.
Journal Article
Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation* On behalf of the Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the ISTH
TL;DR: This poster presents a poster presented at the European Hemophilia and Vascular Biology Conference in Brussels, Belgium, which aims to present a probabilistic picture of the immune system’s response to blood clotting disorders.
Journal ArticleDOI
Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.
Elise S. Eerenberg,Pieter Willem Kamphuisen,Meertien K. Sijpkens,Joost C. M. Meijers,Harry R. Büller,Marcel Levi +5 more
TL;DR: In this article, the authors evaluated the potential of prothrombin complex concentrate (PCC) to reverse the anticoagulant effect of Rivaroxaban and dabigatran.